Delaware
|
001-39438
|
85-1612845
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
297 Boston Post Road #248, Wayland, MA
|
01778
|
|
(Address of principal executive offices)
|
(Zip Code)
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading
Symbol
|
Name of each exchange
on which registered
|
||
Common Stock, par value $0.0001 per share
|
GMTX
|
The Nasdaq Global Market
|
1 |
The Company does not currently maintain a physical headquarters but maintains a mailing address at 297 Boston Post Road #248, Wayland, MA 01778.
|
Item 5.07. |
Submission of Matters to a Vote of Security Holders.
|
For
|
Against
|
Abstain
|
BROKER NON-VOTES |
37,341,199
|
114,070
|
3,520
|
2,843,872 |
For
|
Against
|
Abstain
|
BROKER NON-VOTES |
39,833,612
|
421,352
|
47,697
|
- |
For
|
Against
|
Abstain
|
BROKER NON-VOTES |
32,201,605
|
5,212,578
|
44,606
|
2,843,872 |
For
|
Against
|
Abstain
|
BROKER NON-VOTES |
34,522,687
|
2,891,507
|
44,595 | 2,843,872 |
Item 8.01.
|
Other Events.
|
GEMINI THERAPEUTICS, INC.
|
||
Date: December 28, 2022
|
By:
|
/s/ Georges Gemayel
|
Name:
|
Dr. Georges Gemayel
|
|
Title:
|
Interim President and Chief Executive Officer
|